Press Releases

Report Date Files
Portage makes additional investment in Stimunity S.A. a Paris-Based Cancer immunotherapy company 27 March 2019 Click to open
Portage Announces Change of Auditors 18 March 2019 Click to open
CSE to Issue Final Bulletin Regarding SalvaRx Acquisition 14 February 2019 Click to open
Portage provides updates on trading of its shares on OTC Markets 03 February 2019 Click to open
Shareholders approve Acquisition of SalvaRx Limited 09 January 2019 Click to open
Portage provides additional information on SalvaRx acquisition 19 December 2018 Click to open
Further subscription of US$950,000 in convertible loan to iOx 10 December 2018 Click to open
Portage posts meeting materials; trading on CSE expected to resume shortly; overview of combined Portage/SalvaRx portfolio 28 November 2018 Click to open
Portage announces setting of meeting date to approve SalvaRx acquisition 21 November 2018 Click to open
Portage provides update on proposed acquisition of SalvaRx 10 October 2018 Click to open
Portage Provides update on proposed acquisition of SalvaRx 28 August 2018 Click to open
PORTAGE TO ACQUIRE SALVARX LIMITED 14 August 2018 Click to open
Portage Provides Update on Its Associate, Stimunity 04 June 2018 Click to open
Portage invests in IOX Therapeutics 08 March 2018 Click to open
Portage Invests in Stimunity SA 02 March 2018 Click to open